Magnum sells Orliman to strategic investor
Spanish private equity house Magnum Capital Industrial Partners has sold its entire stake in orthopaedic devices developer Orliman to Spanish pharmaceutical and healthcare business Laboratorios Cinfa.
Financial details surrounding the transaction remain undisclosed.
Previous funding
Buyout house The Riverside Company acquired Orliman in 2011 from the company's founding owners, the Mansergas family, via Riverside Europe Fund IV, a €420m vehicle that closed in November 2010.
Magnum acquired a controlling stake in September 2015 via its second vehicle, Magnum Capital II, in a deal valued at €80m.
Company
Established in 1992 and headquartered in Valencia, Orliman manufactures and distributes non-invasive orthopaedic devices.
The company employs 250 people and posted a €37m turnover in 2015, according to the GP's website, while local press reports claim the business generated €40m in revenues in 2016.
People
Orliman – Enric Florensa (general director).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds









